AI assistant
Sending…
InnoCan Pharma Corporation — Proxy Solicitation & Information Statement 2025
May 7, 2025
47788_rns_2025-05-07_578b18a0-0f1b-42ad-b50f-c496a287a4f5.pdf
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
May 7, 2025
ODYSSEY
Filed via SEDAR+
To All Applicable Exchanges and Securities Administrators
Subject: Innocan Pharma Corporation (the "Issuer") Notice of Meeting and Record Date
Dear Sir/Madam:
We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:
| Meeting Type: | Annual Special Meeting |
|---|---|
| Meeting Date: | June 26, 2025 |
| Record Date for Notice of Meeting: | May 22, 2025 |
| Record Date for Voting (if applicable): | May 22, 2025 |
| Beneficial Ownership Determination Date: | May 22, 2025 |
| Class of Securities Entitled to Vote: | Common Shares |
| ISIN: | CA45783P1027 |
| Issuer sending proxy materials directly to NOBOs: | No |
| Issuer paying for delivery to OBOs: | Yes |
| Notice and Access for Beneficial Holders: | No |
| Notice and Access for Registered Holders: | No |
In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.
Yours truly,
Odyssey Trust Company
as agent for Innocan Pharma Corporation
More from InnoCan Pharma Corporation
Regulatory Filings
2026
May 6
Capital/Financing Update
2026
Apr 6
Regulatory Filings
2026
Apr 6
Capital/Financing Update
2026
Apr 6
Regulatory Filings
2026
Apr 6
M&A Activity
2026
Apr 6
Capital/Financing Update
2026
Apr 6
Regulatory Filings
2026
Apr 3
Capital/Financing Update
2026
Mar 31
Capital/Financing Update
2026
Mar 31